Search

Your search keyword '"Paganetti P"' showing total 297 results

Search Constraints

Start Over You searched for: Author "Paganetti P" Remove constraint Author: "Paganetti P"
297 results on '"Paganetti P"'

Search Results

103. Guidelines for the use and interpretation of assays for monitoring autophagy.

104. The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease

107. LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington’s Disease

108. Automated Monte Carlo Simulation of Proton Therapy Treatment Plans

109. Fractionated Lung IMPT Treatments: Sensitivity to Setup Uncertainties and Motion Effects Based on Single-Field Homogeneity

110. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

111. Using γ-Secretase Inhibitors to Distinguish the Generation of the Aβ Peptides Terminating at Val-40 and Ala-42.

112. Electrophoretic Separation and Immunoblotting of Aβ1-40and Aβ1-42.

114. A Recommendation on How to Analyze In-Room PET for In Vivo Proton Range Verification Using a Distal PET Surface Method

115. Biological Considerations When Comparing Proton Therapy With Photon Therapy.

116. PRELIMINARY STUDY OF PROTON RADIOGRAPHY IMAGING QUALITIES USING GEANT4 MONTE CARLO SIMULATIONS.

117. COMPARISON OF PARTICLE-TRACKING FEATURES IN GEANT4 AND MCNPX CODES FOR APPLICATIONS IN MAPPING OF PROTON RANGE UNCERTAINTY.

118. The disulphide bonds in the catalytic domain of BACE are critical but not essential for amyloid precursor protein processing activity.

119. Expression of human β-secretase in the mouse brain increases the steady-state level of β-amyloid.

120. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation

121. Lifetime Increased Cancer Risk in Mice Following Exposure to Clinical Proton Beam–Generated Neutrons

122. Guidelines for the use and interpretation of assays for monitoring autophagy

123. Design and Testing of a Simulation Framework for Dosimetric Motion Studies Integrating an Anthropomorphic Computational Phantom into Four-dimensional Monte Carlo

124. Consequences of Individual N-glycan Deletions and of Proteasomal Inhibition on Secretion of Active BACE

125. Monte Carlo calculations for absolute dosimetry to determine machine outputs for proton therapy fields

126. The prediction of output factors for spread-out proton Bragg peak fields in clinical practice

127. Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment

128. Structure-Based Design, Synthesis, and Memapsin 2 (BACE) Inhibitory Activity of Carbocyclic and Heterocyclic Peptidomimetics

129. 4D Monte Carlo simulation of proton beam scanning: modelling of variations in time and space to study the interplay between scanning pattern and time-dependent patient geometry

130. Significance and Implementation of RBE Variations in Proton Beam Therapy

131. A Splice Variant of β-Secretase Deficient in the Amyloidogenic Processing of the Amyloid Precursor Protein*

133. Uncertainties and correction methods when modeling passive scattering proton therapy treatment heads with Monte Carlo

134. The mTOR Kinase Inhibitor Everolimus Decreases S6 Kinase Phosphorylation But Fails to Reduce Mutant Huntingtin Levels in Brain and is not Neuroprotective in the R6/2 Mouse Model of Huntington's Disease

139. The Carboxyl Termini of β-Amyloid Peptides 1-40 and 1-42 Are Generated by Distinct γ-Secretase Activities*

140. Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease.

141. Lack of β‐amyloid production in M19 cells deficient in site 2 processing of the sterol regulatory element binding proteins

142. The probability of prompt and delayed fission of muonic237Np

144. Delayed muon induced fission of209Bi and the role of meson-exchange currents

145. The carboxyl termini of beta-amyloid peptides 1-40 and 1-42 are generated by distinct gamma-secretase activities.

146. Intracellular accumulation of beta-amyloid in cells expressing the Swedish mutant amyloid precursor protein.

147. Hadamard transform imager and imaging spectrometer

148. Intracellular Accumulation of β-Amyloid in Cells Expressing the Swedish Mutant Amyloid Precursor Protein (*)

Catalog

Books, media, physical & digital resources